These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
215 related items for PubMed ID: 15125948
1. Potent DNA gyrase inhibitors; novel 5-vinylpyrazole analogues with Gram-positive antibacterial activity. Tanitame A, Oyamada Y, Ofuji K, Suzuki K, Ito H, Kawasaki M, Wachi M, Yamagishi J. Bioorg Med Chem Lett; 2004 Jun 07; 14(11):2863-6. PubMed ID: 15125948 [Abstract] [Full Text] [Related]
2. Design, synthesis and structure-activity relationship studies of novel indazole analogues as DNA gyrase inhibitors with Gram-positive antibacterial activity. Tanitame A, Oyamada Y, Ofuji K, Kyoya Y, Suzuki K, Ito H, Kawasaki M, Nagai K, Wachi M, Yamagishi J. Bioorg Med Chem Lett; 2004 Jun 07; 14(11):2857-62. PubMed ID: 15125947 [Abstract] [Full Text] [Related]
3. Synthesis and antibacterial activity of a novel series of DNA gyrase inhibitors: 5-[(E)-2-arylvinyl]pyrazoles. Tanitame A, Oyamada Y, Ofuji K, Terauchi H, Kawasaki M, Wachi M, Yamagishi J. Bioorg Med Chem Lett; 2005 Oct 01; 15(19):4299-303. PubMed ID: 16087337 [Abstract] [Full Text] [Related]
4. Synthesis and antibacterial activity of a novel series of potent DNA gyrase inhibitors. Pyrazole derivatives. Tanitame A, Oyamada Y, Ofuji K, Fujimoto M, Iwai N, Hiyama Y, Suzuki K, Ito H, Terauchi H, Kawasaki M, Nagai K, Wachi M, Yamagishi J. J Med Chem; 2004 Jul 01; 47(14):3693-6. PubMed ID: 15214796 [Abstract] [Full Text] [Related]
6. Quercetin diacylglycoside analogues showing dual inhibition of DNA gyrase and topoisomerase IV as novel antibacterial agents. Hossion AM, Zamami Y, Kandahary RK, Tsuchiya T, Ogawa W, Iwado A, Sasaki K. J Med Chem; 2011 Jun 09; 54(11):3686-703. PubMed ID: 21534606 [Abstract] [Full Text] [Related]
7. New antibacterial agents derived from the DNA gyrase inhibitor cyclothialidine. Angehrn P, Buchmann S, Funk C, Goetschi E, Gmuender H, Hebeisen P, Kostrewa D, Link H, Luebbers T, Masciadri R, Nielsen J, Reindl P, Ricklin F, Schmitt-Hoffmann A, Theil FP. J Med Chem; 2004 Mar 11; 47(6):1487-513. PubMed ID: 14998336 [Abstract] [Full Text] [Related]
8. 3-aminoquinazolinediones as a new class of antibacterial agents demonstrating excellent antibacterial activity against wild-type and multidrug resistant organisms. Ellsworth EL, Tran TP, Showalter HD, Sanchez JP, Watson BM, Stier MA, Domagala JM, Gracheck SJ, Joannides ET, Shapiro MA, Dunham SA, Hanna DL, Huband MD, Gage JW, Bronstein JC, Liu JY, Nguyen DQ, Singh R. J Med Chem; 2006 Nov 02; 49(22):6435-8. PubMed ID: 17064062 [Abstract] [Full Text] [Related]
10. Novel pyrazole derivatives as potent inhibitors of type II topoisomerases. Part 1: synthesis and preliminary SAR analysis. Gomez L, Hack MD, Wu J, Wiener JJ, Venkatesan H, Santillán A, Pippel DJ, Mani N, Morrow BJ, Motley ST, Shaw KJ, Wolin R, Grice CA, Jones TK. Bioorg Med Chem Lett; 2007 May 15; 17(10):2723-7. PubMed ID: 17368897 [Abstract] [Full Text] [Related]
11. Design, synthesis, and evaluation of novel fluoroquinolone-aminoglycoside hybrid antibiotics. Pokrovskaya V, Belakhov V, Hainrichson M, Yaron S, Baasov T. J Med Chem; 2009 Apr 23; 52(8):2243-54. PubMed ID: 19301822 [Abstract] [Full Text] [Related]